CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-05 | CARUSO JAMES V President and CEO | Purchase · Series H Warrants | +10,870 | $0.01 | $109 | 10,870 |
| 2020-06-04 | HILL STEPHEN A Director | Purchase | +18,000 | $1.08 | $19K | 18,000 |
| 2020-02-03 | Elefant Dov Chief Financial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-02-03 | Longcor Jarrod Chief Business Officer | Grant or award · Stock option (right to buy) | +40,000 | 40,000 | ||
| 2020-02-03 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-03 | Elefant Dov Chief Financial Officer | Grant or award | +10,000 | $2.71 | $27K | 10,000 |
| 2020-02-03 | Longcor Jarrod Chief Business Officer | Grant or award | +40,000 | $2.71 | $108K | 40,000 |
| 2020-02-03 | CARUSO JAMES V President and CEO | Grant or award | +100,000 | $2.71 | $271K | 100,000 |
| 2020-01-06 | Grachev Igor D Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2019-09-10 | Elefant Dov Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2019-06-13 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +6,500 | 6,500 | ||
| 2019-06-13 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +6,500 | 6,500 | ||
| 2019-06-13 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +6,500 | 6,500 | ||
| 2019-06-13 | HILL STEPHEN A Director | Grant or award · Stock option (right to buy) | +6,500 | 6,500 | ||
| 2019-06-13 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +9,750 | 9,750 | ||
| 2019-02-28 | Longcor Jarrod Chief Business Officer | Purchase | +100 | $2.00 | $200 | 7,300 |
| 2019-01-17 | Longcor Jarrod Chief Business Officer | Grant or award · Stock option (right to buy) | +30,000 | 30,000 |
Page 6 of 6 · 117 trades